to Content
Header Image

Pathways to the Nobel Prize – Laureates in Conversation with Austrian Junior Scientists in cooperation with the Foundation Lindau Nobelprizewinners Meetings at Lake Constance

-
Erwin-Schrödinger-Saal
Plenary /
in englischer Sprache
Nobel Laureate in Physiology or Medicine; Director, The G.W. Hooper Research Foundation; Professor and Chancellor Emeritus, University of California, San Francisco
Nobel Laureate in Physiology or Medicine; Morris Herzstein Professor of Biology and Physiology, Department of Biochemistry and Biophysics, University of California, San Francisco
Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge
Group Leader, Junior Research Group Immunotherapy and -prevention, German Cancer Research Center in the Helmholtz Association, Heidelberg
Head, Institute of Medical Genetics; Director, Centre of Pathobiochemistry and Genetics, Medical University of Vienna Chair

MD J. Michael BISHOP

Nobel Laureate in Physiology or Medicine; Director, The G.W. Hooper Research Foundation; Professor and Chancellor Emeritus, University of California, San Francisco

 A.B., Gettysburg College; M.D., Harvard University; Internal Medicine, Massachusetts General Hospital; Postdoctoral Fellow, National Institutes of Health; Assistant to Full Professor, University of California, San Francisco; University Professor, University of California; Director of the G.W.Hooper Research Foundation; Chancellor, University of California, San Francisco; Member and Chair, National Cancer Advisory Board, USA; Numerous other scientific advisory boards; President, American Society for Cell Biology; Nonresident Fellow and Board of Directors, Salk Institute for Biological Sciences.

M.Sc. Ph.D. Elizabeth H. BLACKBURN

Nobel Laureate in Physiology or Medicine; Morris Herzstein Professor of Biology and Physiology, Department of Biochemistry and Biophysics, University of California, San Francisco

1970 B.Sc., Biochemistry, University of Melbourne
1970-1971 Graduate Research Student, Department of Biochemistry, University of Melbourne
1971-1974 Graduate Research Student, Division Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Cambridge
1972 M.Sc., Molecular Biology, University of Cambridge
1975 Ph.D, Molecular and Cell Biology, University of Camebridge
1975-1977 Postdoctoral Fellow, Department of Biology, Yale University
1978 Postdoctoral Fellow, University of California, San Francisco
1978-1983 Assistant Professor, Department of Molecular Biology, University of California Berkeley
1983-1986 Associate Professor, Department of Molecular Biology, University of California, Berkeley
1986-1990 Professor, Department of Molecular Biology, University of California, Berkley
since 1990 Professor, Department of Biochemistry and Biophysics, and Microbiology and Immunology, University of California, San Francisco
1993-1999 Chair, Department of Microbiology and Immunology, University of California, San Francisco

Dr. Lukas NIEDERREITER

Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge

2004-2010 M.D., Medical University Innsbruck
2008-2010 M.D. Diploma thesis "ER stress transcription factor Xbp1 regulates NFkB activity in intestinal epithelial cells" supervisor Prof. Arthur Kaser
since 2010 Phd in Medicine, University of Cambridge

DDr. Angelika RIEMER

Group Leader, Junior Research Group Immunotherapy and -prevention, German Cancer Research Center in the Helmholtz Association, Heidelberg

1995-2001 Medizinstudium an der Universität Wien (inkl. B.Sc.-Austauschsemester in Immunologie, Melbourne, Australien; und ERASMUS-Semester in Bristol, England)
2002 Promotion zur Doktorin der gesamten Heilkunde (Dr. med. univ.) sub auspiciis praesidentis rei publicae
ab 2001 Facharztausbildung in Immunologie
2002-2004 Doktoratsstudium Molekularbiologie, Universität Wien
2005 Promotion zur Doktorin der Naturwissenschaften (Dr. rer. nat.) sub auspiciis praesidentis rei publicae
ab 2005 Facharztausbildung in Dermatologie
2007 Habilitation im Fach Immunologie
2008-2009 Postdoctoral Research Fellow, Cancer Vaccine Center, Dana-Farber Cancer Institute / Harvard Medical School
2010 Fachärztin für Immunologie
ab 2010 Gruppenleiterin am Deutschen Krebsforschungszentrum, Heidelberg Nachwuchsgruppe "Immuntherapie und -prävention"
2010 Umhabilitation an die Universität Heidelberg

Mag. Dr. Markus HENGSTSCHLÄGER

Head, Institute of Medical Genetics; Director, Centre of Pathobiochemistry and Genetics, Medical University of Vienna

1986-1990 Studium Genetik, Diplomarbeit am Children Cancer Research Institute St. Anna Kinderspital, Sponsion zum Magister der Genetik (Auszeichnung, Studienverkürzung)
1990-1992 Dissertation als Universitätsassistent am Vienna Biocenter, Promotion zum Doktor der Genetik (Auszeichnung)
1993-1994 Postdoc an der Yale University, USA
1995 Universitätsassistent Universität Wien
1997 Habilitation
1998 außerordentlicher Universitätsprofessor
2004 Ausbildungsabschluss: Fachhumangenetiker
Berufung (internationales Berufungsverfahren) zum Universitätsprofessor für Medizinische Genetik an der Medizinischen Universität Wien
seit 2004 Moderator der Medizin- und Wissenschaftssendung "Radiodoktor", ORF, Ö1 Radio
seit 2005 Leiter der Abteilung Genetik, Institut für Kinderwunsch, Lainzerstraße, Wien
2005-2009 Leiter der Abteilung für Medizinische Genetik, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
seit 2009 Vorstand des Instituts für Medizinische Genetik, Medizinische Universität Wien
seit 2011 zusätzlich Organisationseinheitsleiter des Zentrum für Pathobiochemie und Genetik der Medizinischen Universität Wien
 - Wissenschaftliche Arbeitsgebiete: Erforschung der humangenetischen Erkrankung Tuberöse Sklerose; Stammzellen aus dem humanen Fruchtwasser; Deregulation von Zelldifferenzierungsprozessen bei humangenetischen Erkrankungen; pränatale und postnatale genetische Routinediagnostik; Genetik in der Reproduktionsmedizin; Bioethik (Schwerpunkt medizinische Genetik und Stammzellforschung).
 - Alleinverantwortliche Verfassung und Leitung der Durchführung einer Vielzahl von Drittmittel-Projekten gefördert durch z.B. Fonds zur Förderung der wissenschaftlichen Forschung (FWF), Marie Curie Research Network (Forschungsförderung der Europäischen Union), Oesterreichische Nationalbank, Bundesministerium für Wissenschaft und Verkehr, Herzfeldersche Familienstiftung, Komission Onkologie der
 Wiener Medizinischen Fakultät, Anton-Dreher-Gedächtnisstiftung, Hochschuljubiläumsstiftung der Stadt Wien.

Technology Forum

show timetable
Genre : all

23.08.2012

08:00 - 10:30Technology Brunch hosted by Standortagentur TirolSocial
11:00 - 11:10Welcome statementPlenary
11:10 - 11:30Opening of the Alpbach Technology Forum 2012Plenary
11:30 - 12:15Opening SpeechesPlenary
12:15 - 13:05Powering the FuturePlenary
13:25 - 14:55Global Earth Research – Research for the Future of the Globe in cooperation with the Helmholtz Association of German Research CentersPlenary
14:55 - 15:45The Fight against Cancer – Breakthroughs and ExpectationsPlenary
18:00 - 19:30The global Competition for Production and Research – who will determine the Future?Plenary
19:30 - 21:30Evening Reception hosted by Forschung AustriaSocial
19:30 - 21:30Career Lounge – Evening event with a buffet dinner for students, graduate scientists and young professionals, hosted by the organisers of the Alpbach Technology Forum and Siemens AG ÖsterreichSocial

24.08.2012

07:00 - 13:30Working Group 01: Key Technologies – a Future for Europe’s YouthBreakout
07:00 - 13:30Working Group 02: Ambient Assisted LivingBreakout
07:00 - 13:30Working Group 03: Smart City – Human beings at the Focus of AttentionBreakout
07:00 - 13:30Working Group 04: Demographics and Human Resources as an Opportunity for InnovationBreakout
07:00 - 13:30Working Group 05: The Location of future Production Sites – Decision Criteria, Opportunities and RisksBreakout
07:00 - 13:30Working Group 06: Supporting Careers in ScienceBreakout
07:00 - 13:30Working Group 07: Key Elements of successful Innovation CulturesBreakout
07:00 - 13:30Working Group 08: Learning through innovative Education NetworksBreakout
07:00 - 13:30Working Group 09: Wanted: young, technologically savvy, curiousBreakout
07:00 - 13:30Working Group 10: Smart Governance for smart SpecialisationBreakout
07:00 - 13:30Working Group 11: Medical technology: challenges and opportunitiesBreakout
07:00 - 13:30Working Group 12: Cyber-security as a critical factory of stabilityBreakout
07:00 - 13:30Working Group 13: Modern Technologies and their Role in Democratic ProcessesBreakout
07:00 - 16:00Junior Alpbach – Science and Technology for Young PeopleBreakout
07:00 - 13:00Ö1 Children’s University Alpbach – Science and Technology for KidsBreakout
07:45 - 13:00Special Event: RTI Internationalisation in Austria and the EUBreakout
14:00 - 15:15Individualisation – the Basis for Education and InnovationPlenary
15:30 - 17:30Pathways to the Nobel Prize – Laureates in Conversation with Austrian Junior Scientists in cooperation with the Foundation Lindau Nobelprizewinners Meetings at Lake ConstancePlenary

25.08.2012

07:00 - 08:30Emerging Technologies that will change our Lives – a Selection of EU “Flagship Projects”Plenary
08:45 - 10:00Future Scenarios: how long can we plan ahead?Plenary
10:00 - 11:05The physics of footballPlenary
11:05 - 11:15Closing StatementPlenary
11:20 - 12:00Snack ReceptionSocial